您当前所在位置:首页 > 材料科学 > 新品上市
序号 标题 次数 作者 发布时间
75781 CAS: 2768446-73-5,DBCO-Val-Cit-PAB-MMAE 79 WYQ 2024-12-19
75782 MC-vc-PAB-C6-a-amanitin, ADC试剂 70 kx 2024-12-19
75783 cas:663598-98-9,2,5-dioxopyrrolidin-1-yl 4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoate,ADC定制 91 wyh 2024-12-19
75784 cas:2873452-49-2 MC-EVCit-PAB-MMAE 88 zyl 2024-12-19
75785 2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate,ADC定制 95 wyh 2024-12-19
75786 cas:159857-70-2 MC-Val-Cit-Doxorubicin 118 zyl 2024-12-19
75787 Gly3-vc-PAB-MMAE, ADC试剂 103 kx 2024-12-19
75788 CAS: 1869126-64-6, Azido-PEG4-Val-Cit-PAB-MMAE 87 WYQ 2024-12-19
75789 cas:2353409-54-6 , Mal-amido-PEG8-Val-Gly,ADC定制 104 wyh 2024-12-19
75790 Azido-PEG4-Val-Ala-PAB-PNP 99 zyl 2024-12-19
75791 NOTA-(NGR)2 NOTA偶联NGR二聚体 79 h 2024-12-19
75792 1-(2,5-dioxopyrrolidin-1-yloxy)-4-((5-nitropyridin-2-yl)disulfanyl)-1-oxobutane-2-sulfonic acid,ADC定制 89 wyh 2024-12-19
75793 CAS: 1343476-44-7,Val-Ala-PAB-OH 79 WYQ 2024-12-19
75794 MC-PBD, ADC试剂 88 kx 2024-12-19
75795 Mal-Val-Ala-PAB的介绍 90 zyl 2024-12-19
75796 DOTA-K-A9 1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)结合肽A9 79 h 2024-12-19
75797 Azide-PEG3-Val-Cit-PAB-MMAF,叠氮-三聚乙二醇-Val-Cit-PAB-MMAF 84 WYQ 2024-12-19
75798 Arm-DOTA-B72.3 79 h 2024-12-19
75799 cas:1884577-99-4 Boc-Val-Ala-PAB 93 zyl 2024-12-19
75800 (Lys(DOTA)4)BVD15 DOTA偶联神经肽Y(NPY)类似物 126 h 2024-12-19
75801 1801838-28-7,Mc-vc-PAB-SN38,化合物MC-VC-PAB-SN38 87 kx 2024-12-19
75802 DOTA-PPI 1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)-官能化的聚(丙烯亚胺)(PPI)糖树枝状分子 89 h 2024-12-19
75803 CAS: 863971-17-9,MC-Val-Cit-PAB-MMAF 111 WYQ 2024-12-19
75804 cas:1884577-99-4 Boc-Val-Ala-PAB 124 zyl 2024-12-19
75805 DBCO-PEG4-vc-PAB-MMAE, ADC试剂 112 kx 2024-12-19
75806 1884578-00-0,Boc-PEG4-Val-Ala-PAB-PNP,ADC定制 114 wyh 2024-12-19
75807 DOTA-Peg-Cpa-c[DCys-Aph(Cbm)-DTrp-Lys-Thr-Cys]-2Nal-NH2 78 h 2024-12-19
75808 DOTA-2.5D DOTA-胱氨酸结肽(knottins)2.5D和2.5F 94 h 2024-12-19
75809 二苯并环辛炔-四聚乙二醇-VAL-ALA-PAB,ADC定制 114 wyh 2024-12-19
75810 Hz220(DOTA-Lys(IR dye 650)-PEa(4)-[D-Phe(6)DOTA偶联的GRPr拮抗剂 91 h 2024-12-19
75811 Azido-PEG4-MMAE,抗体药物偶联物(ADCs) 124 WYQ 2024-12-19
75812 1626359-62-3,SPDB-DM4, ADC试剂 81 kx 2024-12-19
75813 Acid-PEG4-Val-Cit-PAB-MMAE,包含PEG链和MMAE等部分 88 WYQ 2024-12-19
75814 cas:159857-70-2,MC-Val-Cit-Doxorubicin,ADC定制 110 wyh 2024-12-19
75815 DOTA-(D)Phe(1)-Tyr(3) 83 h 2024-12-19
75816 cas:1884577-99-4 Boc-Val-Ala-PAB 124 zyl 2024-12-19
75817 FAM-amido hexamethylene carbamate-PAB-Cit-Val-Alkyne 125 WYQ 2024-12-19
75818 DOTA-l-Nal3-octreotide DOTA-l-nal3-奥曲肽 82 h 2024-12-19
75819 CAS: 2762518-86-3 ,NHS ester-PEG4-Val-Cit-PAB-MMAE 95 WYQ 2024-12-19
75820 cas:2873452-49-2 ; MC-EVCit-PAB-MMAE,ADC定制 114 wyh 2024-12-19
75821 CAS: 2762519-08-2 endo-BCN-PEG4-Val-Cit-PAB-MMAE,内末端二苯卡宾吡啶甲酸乙酯聚乙二醇4个单元赖氨酸缬氨酸丙氨酸天冬氨酸 131 WYQ 2024-12-19
75822 cas:863971-24-8,Mc-MMAE ,马来酰亚胺基己酰-单甲基澳瑞他汀 E 168 kx 2024-12-19
75823 DOTA-(AEEA)2-BN DOTA-(AEEA)2-铃蟾肽 86 h 2024-12-19
75824 cas:2259318-55-1 , DBCO-(PEG2-VC-PAB-MMAE)2,ADC定制 96 wyh 2024-12-19
75825 cas:1394238-91-5 Fmoc-Val-Ala-PAB 116 zyl 2024-12-19
库存查询